Clinical Trials on Urinary Incontinence in New Zealand
Total 8311 results
-
PfizerCompletedRenal ImpairmentUnited States
-
Far Eastern Memorial HospitalRecruitingOveractive Bladder SyndromeTaiwan
-
Far Eastern Memorial HospitalRecruitingOveractive Bladder SyndromeTaiwan
-
Far Eastern Memorial HospitalWithdrawnOveractive Bladder SyndromeTaiwan
-
Monash UniversityNational Health and Medical Research Council, Australia; Cerebral Palsy Alliance and other collaboratorsRecruitingFetal Growth Retardation | Pregnancy Preterm | Stillbirth and Fetal DeathAustralia, New Zealand
-
Icahn School of Medicine at Mount SinaiCompletedOveractive Bladder | Pelvic Organ ProlapseUnited States
-
UroGen Pharma Ltd.CompletedNeoplasms | Urologic Neoplasms | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder NeoplasmsIndia
-
Yale UniversityCompletedUrinary Tract InfectionUnited States
-
PfizerCompletedTreatment of Overactive BladderUnited States
-
Northwell HealthMedtronics, Inc.CompletedDetrusor OveractivityUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBladder Cancer | High Risk SuperficialUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; New York Presbyterian HospitalTerminatedBladder CancerUnited States
-
PfizerCompletedTreatment of Overactive BladderUnited States
-
NYU Langone HealthSociety of Abdominal RadiologyCompletedBladder CancerUnited States
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; New York Presbyterian HospitalTerminated
-
Icahn School of Medicine at Mount SinaiCompleted
-
GlaxoSmithKlineCompletedOveractive BladderAustralia
-
Far Eastern Memorial HospitalRecruiting
-
Columbia UniversityCompletedBladder Cancer | ComplicationsUnited States
-
Memorial Sloan Kettering Cancer CenterAmgenTerminated
-
Osprey Medical, IncCompletedContrast Induced Nephropathy (CIN)United States, New Zealand, Australia
-
St. Luke's-Roosevelt Hospital CenterCompletedInfertilityUnited States
-
Matthew GalskyNovartisTerminatedBladder Cancer | Solid TumorsUnited States
-
Weill Medical College of Cornell UniversityPfizerCompletedBladder Outlet ObstructionUnited States
-
NYU Langone HealthCompletedOveractive BladderUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBladder CancerUnited States
-
Columbia UniversityCelgene CorporationUnknownBladder CancerUnited States
-
Far Eastern Memorial HospitalCompletedOveractive Bladder SyndromeTaiwan
-
NYU Langone HealthWithdrawn
-
NovartisCompletedOveractive Bladder SyndromeUnited States
-
En Chu Kong HospitalCompleted
-
NovartisCompletedOveractive Bladder SyndromeUnited States
-
Ascher-Walsh, Charles, M.D.CompletedVesicovaginal Fistula | Delivery of HealthcareUnited States
-
Arrowhead PharmaceuticalsRecruitingIgA Nephropathy | C3 GlomerulopathyNew Zealand, Australia, Korea, Republic of, Thailand, Germany, United Kingdom, Georgia
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Incyte Corporation; Celldex TherapeuticsCompletedFallopian Tube Carcinoma | Ovarian Carcinoma | Primary Peritoneal CarcinomaUnited States
-
University of RochesterTerminatedUrinary Tract Infection | Prostate Cancer | Clostridium DifficileUnited States
-
University of RochesterAstellas Pharma IncTerminated
-
Progyny, Inc.Completed
-
Atlantic Health SystemCompletedUrinary RetentionUnited States
-
Urovant Sciences GmbHIon Channel InnovationsCompletedOveractive BladderUnited States
-
Asieris Pharmaceuticals (AUS) Pty Ltd.Completed
-
Edward MessingImagin MedicalCompleted
-
PfizerCompletedOveractive Bladder (OAB) With Symptoms of Frequency, Urgency, and UrgencyUnited States
-
St George Hospital, AustraliaCompletedUrinary RetentionAustralia
-
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...Recruiting
-
University of TennesseeUniversity of Tennessee Health Science CenterCompleted
-
VA New York Harbor Healthcare SystemCompletedNephrolithiasis | Urolithiasis | Kidney StonesUnited States
-
University of SydneyNational Health and Medical Research Council, Australia; Mylan Pharmaceuticals... and other collaboratorsRecruitingDiabetic Retinopathy | Diabetic Nephropathies | Type 1 Diabetes MellitusAustralia, Hong Kong, New Zealand